Mikhail A. Boldyrev

Mikhail A. Boldyrev

Auto-generated profile, based on publicly available information

Mikhail A. Boldyrev


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Clinical and Experimental Surgery. Petrovsky journal
Verified
Journal Article
Closed access
M(Moscow Regional Research and Clinical Institute (“MONIKI”)
Moscow Regional Research and Clinical Institute (“MONIKI”)
ASA.V. Semenkov
A.V. Semenkov
IUI.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenov University)
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenov University)
DPD.A. Pyhteev
D.A. Pyhteev
VMV.YU. Malyuga
V.YU. Malyuga
ASA.L. Skugarev
A.L. Skugarev
Клиническое значение эктопии поджелудочной железы в различные органы (обзор литературы и клинические наблюдения симптомного и бессимптомного течения)

10 January 2026 in Russian Journal of Transplantology and Artificial Organs
Verified
Journal Article
Open access
PDF file
MBM. A. Boldyrev
M. A. Boldyrev
AMA. R. Monakhov
A. R. Monakhov
NGN. V. Grudinin
N. V. Grudinin
VBV. K. Bogdanov
V. K. Bogdanov
SZS. I. Zubenko
S. I. Zubenko
CГC. В. Готье
C. В. Готье
Objective: to assess the effi cacy and safety of combining sequential dual hypothermic oxygenated machine perfusion (DHOPE), controlled oxygenated rewarming (COR), and normothermic machine perfusion (NMP) with ischemia-free liver implantation (IFLI) for transplants obtained from high-risk expanded criteria donors (ECDs). Materials and methods . The study presents two cases of liver transplantation performed using the combined DHOPE-COR-NMP-IFLI protocol in May and June 2025 at the Shumakov National Medical Research Center of Transplantology and Artifi cial Organs. Liver allografts were procured from brain-dead ECDs. Perfusion was carried out using a cardiopulmonary bypass (CPB) machine following a period of static cold storage (SCS). The allografts were subsequently transplanted into recipients under continuous NMP after meeting viability criteria. The reproducibility and safety of the IFLI approach within the combined protocol were evaluated through descriptive analysis of donor characteristics, perfusion parameters, and intra- and postoperative outcomes in the recipients. Results . In both cases, the grafts met the established viability criteria despite pronounced macrovesicular steatosis (95% and 80%, respectively). In Case No. 1, all viability parameters were achieved after 4 hours of NMP. In Case No. 2, lactate clearance was suboptimal, reaching the acceptable threshold of 4.1 mmol/L only after 6 hours of perfusion. No post-perfusion syndrome or hemodynamic instability occurred in either recipient during graft reperfusion. Both recipients met the criteria for early allograft dysfunction, with cytolysis levels of 6562.9 and 1610.4 U/L, and 3822 and 2662 U/L, respectively. The recipients were discharged on postoperative days 17 and 34 without serious complications (Clavien–Dindo ≥IIIb). At 4- and 5-month follow-up, no transplant- or preservation-related complications were observed. Conclusion . The combined application of sequential machine perfusion (DHOPE-COR and NMP) with IFLI is a safe and eff ective dynamic preservation strategy. This approach enables the successful use of liver grafts from ECDs by minimizing ischemia–reperfusion injury.

19 August 2026 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
YBYulia Basok
Yulia Basok
EKEugenia Kuznetsova
Eugenia Kuznetsova
ABAleksandra D. Belova
Aleksandra D. Belova
DMDmitriy A. Morozov
Dmitriy A. Morozov
MBMikhail A. Boldyrev
Mikhail A. Boldyrev
SGSergey V. Gautier
Sergey V. Gautier
A comprehensive assessment of allograft quality is essential for predicting successful transplantation and graft survival. Elevated levels of flavin mononucleotide (FMN) in perfusate obtained during hypothermic oxygenated perfusion (HOPE) may serve as a promising predictor of early graft dysfunction and post-transplant complications. The aim of this study was to evaluate the feasibility of applying an FMN determination method to HTK-based perfusion solutions used during liver machine perfusion. The spectrofluorimetric method for FMN determination in modified HTK perfusion solution (modHTK) was evaluated for the following parameters: linearity, accuracy, repeatability, reproducibility, and stability. The study demonstrated the suitability of the quantitative FMN determination method for modHTK solution used during HOPE of liver grafts.

1 January 2021 in Clinical and Experimental Surgery. Petrovsky journal
Verified
Journal Article
Closed access
VSV.S. Subbot
V.S. Subbot
IUI.M. Sechenov First Moscow State Medical University University of the Ministry of Healthcare of the Russian Federation (Sechenov University)
I.M. Sechenov First Moscow State Medical University University of the Ministry of Healthcare of the Russian Federation (Sechenov University)
ASA.V. Semenkov
A.V. Semenkov
ASA.A. Shiryayev
A.A. Shiryayev
TNT.P. Nekrasova
T.P. Nekrasova
NYN.D. Yudayev
N.D. Yudayev